Company Analysis

NanoViricides Inc. (NNVC)

NYSE: NNVC · Pharmaceutical Preparations · Shelton, CT · filing with the SEC since 2006
Grade4.9
◀ Past 5.2● Present 5.1▶ Future 4.4
5 est.

Filings

197 filings since 2017 beside 7 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Sep 28, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 8, 2026.

Filings a yearinsider forms included
2542131117171629
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Sep 29, 2026.SEC letters: 10 in the last 36 months, the newest Jun 23, 2026.
Insider forms 7

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 21, 2026 424B5 Shelf offering
Oct 8, 2026 DEF 14A Proxy statement Nov 21, 2026
Sep 29, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Sep 28, 2026
Sep 28, 2026 10-K Annual report Jun 30, 2026
Sep 3, 2026 424B3 Shelf offering
Aug 31, 2026 EFFECT Registration effective
Aug 21, 2026 S-3 Shelf registration
Jul 30, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report Jul 24, 2026
Jul 27, 2026 424B5 Shelf offering
Jul 27, 2026 424B5 Shelf offering
Jul 17, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Jul 17, 2026 424B5 Shelf offering
Jul 1, 2026 424B3 Shelf offering
Jun 26, 2026 EFFECT Registration effective
Jun 23, 2026 CORRESP Reply to the SEC
Jun 22, 2026 DEL AM Form DEL AM
Jun 18, 2026 UPLOAD SEC comment letter
Jun 17, 2026 DEL AM Form DEL AM
Jun 15, 2026 EFFECT Registration effective
Jun 15, 2026 S-3 Shelf registration
Jun 11, 2026 CORRESP Reply to the SEC
Jun 10, 2026 UPLOAD SEC comment letter
Jun 5, 2026 S-3 Shelf registration
May 21, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report May 20, 2026
May 20, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report May 15, 2026
May 18, 2026 424B5 Shelf offering
May 15, 2026 10-Q Quarterly report Mar 31, 2026
Feb 25, 2026 D Private placement notice
Feb 17, 2026 10-Q Quarterly report Dec 31, 2025
Dec 30, 2025 424B3 Shelf offering
Dec 19, 2025 EFFECT Registration effective
Dec 18, 2025 CORRESP Reply to the SEC
Dec 16, 2025 DEL AM Form DEL AM
Dec 15, 2025 S-3 Shelf registration
Nov 26, 2025 8-K item 5.07 Shareholder vote · Current report Nov 22, 2025
Nov 14, 2025 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report Nov 10, 2025
Nov 14, 2025 10-Q Quarterly report Sep 30, 2025
Nov 12, 2025 424B5 Shelf offering
Nov 12, 2025 424B5 Shelf offering
Oct 8, 2025 DEF 14A Proxy statement Nov 8, 2025
40 of 197 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton NNVC · research, not advice